Exploring Key Insights of the Pharmaceutical Continuous Manufacturing Market: Growth Prospects, Emerging Trends, and Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the pharmaceutical continuous manufacturing market grown in recent years?
The steady expansion of the pharmaceutical continuous manufacturing market in recent years is noteworthy. The market is projected to boost from $2.47 billion in 2024 to $2.72 billion in 2025, with an impressive compound annual growth rate (CAGR) of 10.2%. The substantial growth witnessed in the past period is attributed to improved quality and efficiency, decreased time-to-market, cost reductions and operational efficiencies, regulatory support and provisions, as well as flexibility and scalability.
How is the pharmaceutical continuous manufacturing market size expected to evolve during the forecast period?
In the coming years, the market size of pharmaceutical continuous manufacturing is predicted to witness accelerated growth, ballooning to $4.15 billion in 2029, with a compound annual growth rate (CAGR) of 11.2%. The market expansion during the forecasted period can be credited to the surge in generic drug production, biopharmaceutical manufacturing, personalized medicine manufacturing, and a growing focus on patient-centric approaches. The forecast period will also see major market trends such as the embrace of continuous manufacturing, incorporation of process analytical technology, the application of advanced automation and robotics, formation of strategic collaborations and partnerships, and strides in digitalization and connectivity.
Get your pharmaceutical continuous manufacturing market report here!
Which key drivers are propelling the pharmaceutical continuous manufacturing market’s growth?
The escalating occurrence of various chronic diseases is anticipated to fuel the expansion of the pharmaceutical continuous manufacturing market in the future. Chronic illnesses, generally, are those that last for a year or more, necessitate ongoing medical attention, and impact day-to-day activities. Continuous manufacturing approaches empower pharmaceutical firms to smooth out medication production, inevitably contributing to heightened efficiency and reduced costs. This method also expands access to crucial drugs, which is particularly significant for managing chronic conditions that entail long-term medication use. As an example, in April 2022, a report by the National Association of Chronic Disease Directors (NACDD), a charitable Public Health organization in the US specializing in chronic disease programmes, stated that nearly 60 % of adult Americans suffer from at least one chronic disease, and about 40% of American adults have multiple chronic conditions (MCC). This is projected to burden the US economy with a cost of $2 trillion annually, or $8,600 per individual by 2030. As such, the escalating occurrence of various chronic diseases will push the growth of the pharmaceutical continuous manufacturing market.
What are the market segments in the pharmaceutical continuous manufacturing industry?
The pharmaceutical continuous manufacturing market covered in this report is segmented –
1) By Product: Integrated Continuous System, Control And Software, Semi-Continuous System
2) By Therapeutics Type: Large Molecule, Small Molecule
3) By Formulation: Solid Formation, Liquid And Semi-Solid Formation
4) By Application: Final Drug Product Manufacturing, Active Pharmaceutical Ingredient (API) Manufacturing
5) By End-Users: Pharmaceutical Companies, Contract Manufacturing Organization, Other End-Users
Subsegments:
1) By Integrated Continuous System: Continuous Mixer Systems, Continuous Granulation Systems, Continuous Tablet Press Systems, Continuous Coating Systems
2) By Control and Software: Process Analytical Technology (PAT) Tools, Manufacturing Execution Systems (MES), Control Software for Automation, Data Management and Visualization Software
3) By Semi-Continuous System: Batch-to-Continuous Transition Systems, Hybrid Systems, Semi-Continuous Granulation and Drying Systems
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12123&type=smp
Which leading companies are shaping the growth of the pharmaceutical continuous manufacturing market?
Major companies operating in the pharmaceutical continuous manufacturing market include Pfizer Inc., Robert Bosch GmbH, Siemens AG, Novartis AG, Thermo Fisher Scientific Inc., GlaxoSmithKline Plc., Eli Lilly and Company, Corning Inc., Vertex Pharmaceuticals, Lonza Group Ltd., GEA Group AG, Catalent Inc., Mettler Toledo, Patheon, Cytiva, Samsung Biologics Co.Ltd., WuXi Biologics, Syntegon Technology GmbH, Coperion GmbH, Hosokawa Micron Group, FUJIFILM Diosynth Biotechnologies, Leistritz AG, Glatt GmbH, Freund-Vector Corp., SK biotek Co. Ltd., Gericke AG, GEBRÜDER LÖDIGE MASCHINENBAU GmbH, Munson Machinery Company Inc., L.B. Bohle Maschinen und Verfahren GmbH, KORSCH AG, Chemtrix BV
What key trends are currently impacting the pharmaceutical continuous manufacturing market’s development?
Technological advancements are emerging as a significant trend in the pharmaceutical continuous manufacturing market. Leading companies in this market are launching new products to maintain their competitive edge. For instance, The United States Pharmacopeia (USP), a US-based non-profit organization that owns the trademark and copyright on the Pharmacopeia National Formulary (USP-NF), rolled out the USP Advanced Manufacturing Technology Lab in December 2022, introducing R&D analytical solutions. These services would assist pharmaceutical manufacturers in employing advanced manufacturing technologies, such as pharmaceutical continuous manufacturing (PCM), to diversify their manufacturing locations geographically and bolster the resilience of the medicine supply chain. This would involve delineating materials and establishing and qualifying methods for ensuring the quality of PCM-based medications.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12123
Which geographic areas are influencing the growth of the pharmaceutical continuous manufacturing market?
Western Europe was the largest region in the pharmaceutical continuous manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical continuous manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Styrene Butadiene Rubber (SBR) Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/styrene-butadiene-rubber-sbr-global-market-report
Automotive Garage Equipment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/automotive-garage-equipment-global-market-report
Green Tires Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/green-tires-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
